Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer
已完结
10
由 达姆 发布于 2026/5/7 15:51:07
DOI:10.1016/j.annonc.2025.11.002
作者：L. Cabel ,?F. Berger ,?T. Bachelot ,?B. Pistilli ,?F. Dalenc ,?T. de la Motte Rouge ,?R. Sabatier ,?A. Lortholary ,?S. Marques ,?J. Vibert ,?S. Renault ,?A.C. Hardy-Bessard ,?S. Delaloge ,?A. Pradines
文献类型：期刊论文
补充材料：只需要正文
作者：L. Cabel ,?F. Berger ,?T. Bachelot ,?B. Pistilli ,?F. Dalenc ,?T. de la Motte Rouge ,?R. Sabatier ,?A. Lortholary ,?S. Marques ,?J. Vibert ,?S. Renault ,?A.C. Hardy-Bessard ,?S. Delaloge ,?A. Pradines
文献类型：期刊论文
补充材料：只需要正文
Elsevier
应助信息
6小时前
小丹
202605071657510994785.pdf
已采纳
8小时前
Book学术机器人
2026/5/7 15:51:07
未找到该文献，机器人已退出，请等待人工下载
2026/5/7 15:51:07
Book学术AI机器人收到请求，开始寻找文献
2026/5/7 15:51:07
已向机器人发送请求
8小时前
达姆
发布求助
上一个求助:
其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary
下一个求助:
American Association for Cancer Research (AACR)Returning to PARP inhibition: Rechallenge with Bevacizumab in Ovarian Cancer.
其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary
下一个求助:American Association for Cancer Research (AACR)Returning to PARP inhibition: Rechallenge with Bevacizumab in Ovarian Cancer.
京公网安备 11010802042870号
